When Innovation Meets Compliance

Nerhapezil… The Only Donepezil (Acetylcholinesterase Inhibitor) In Egypt With ODF Technology

The Formula of Success

  • Nerhapezil: The Only Donepezil (Acetylcholinesterase Inhibitor) In Egypt With ODF Technology
  • Nerhapezil: Donepezil HCl has Proven Efficacy in Management of Alzheimer’s Disease.
  • Nerhapezil: The Only Selective Non-Competitive Rapid Reversible ACHI for Alzheimer’s Disease Patients.
  • Nerhapezil: FDA Approved for Use Across the Full Spectrum Alzheimer’s Disease (Mild – Moderate – Severe).
  • Nerhapezil: Significantly Improves Cognition & Social Behavior in Alzheimer’s Disease Patients.
  • Nerhapezil: The Highest Tolerability with The Least Side Effects Among Other Acetylcholinesterase Inhibitors Prescribed for Alzheimer’s Disease.
  • Nerhapezil: For the Best Patient’s Compliance :
    1. Easier Intake & Administration.
    2. Smarter Route of Administration.
    3. Greater Patient Adherence to Therapy.

Indications

NERHAPEZIL

is indicated for the symptomatic treatment of mild to moderately sever Alzheimer’s dementia ”

Dosage & administration

 Ondalenz…Instruction of use

Dosage & administration

Once daily at bedtime.